Magainin 2 in action: Distinct modes of membrane permeabilization in living bacterial and mammalian cells

Biophysical Journal

Volumn 95, Issue 12, 2008, Pages 5757-5765

  Imura, Yuichi ^a   Choda, Naoki ^a   Matsuzaki, Katsumi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLYCOSAMINOGLYCAN; LIPID; MAGAININ 2; PEPTIDE; TETRAMETHYLRHODAMINE; MAGAININ DERIVATIVE;

ADULT; ANIMAL CELL; ARTICLE; BACILLUS MEGATERIUM; BACTERIAL CELL; BACTERIAL MEMBRANE; CELL NUCLEUS; CHO CELL; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOSOL; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; MALE; MAMMAL CELL; MEMBRANE PERMEABILITY; MITOCHONDRION; NONHUMAN; XENOPUS LAEVIS; AMINO ACID SEQUENCE; ANIMAL; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CHEMISTRY; CRICETULUS; CYTOLOGY; DRUG EFFECT; HAMSTER; METABOLISM; MOLECULAR GENETICS;

BACILLUS MEGATERIUM; BACTERIA (MICROORGANISMS); CRICETULUS GRISEUS; MAMMALIA; XENOPUS LAEVIS;

AMINO ACID SEQUENCE; ANIMALS; BACILLUS MEGATERIUM; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CHO CELLS; CRICETINAE; CRICETULUS; MAGAININS; MOLECULAR SEQUENCE DATA;

EID: 58749085926     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1529/biophysj.108.133488     Document Type: Article

References (55)

1. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature. 415:389-395.
2. Hancock, R. E., and H. G. Sahl. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557.
3. Zasloff, M., B. Martin, and H. C. Chen. 1988. Antimicrobial activity of synthetic magainin peptides and several analogues. Proc. Natl. Acad. Sci. USA. 85:910-913.
4. Wade, D., A. Boman, B. Wahlin, C. M. Drain, D. Andreu, H. G. Boman, and R. B. Merrifield. 1990. All-D amino acid-containing channel-forming antibiotic peptides. Proc. Natl. Acad. Sci. USA. 87:4761-4765.
5. Matsuzaki, K., M. Harada, S. Funakoshi, N. Fujii, and K. Miyajima. 1991. Physicochemical determinants for the interactions of magainins 1 and 2 with acidic lipid bilayers. Biochim. Biophys. Acta. 1063:162-170.
6. Zasloff, M. 1987. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA. 84:5449-5453.
7. Matsuzaki, K. 1998. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim. Biophys. Acta. 1376:391-400.
8. Huang, H. W. 2006. Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim. Biophys. Acta. 1758:1292-1302.
9. Takeshima, K., A. Chikushi, K. K. Lee, S. Yonehara, and K. Matsuzaki. 2003. Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes. J. Biol. Chem. 278:1310-1315.
10. Tomasinsig, L., B. Skerlavaj, N. Papo, B. Giabbai, Y. Shai, and M. Zanetti. 2006. Mechanistic and functional studies of the interaction of a proline-rich antimicrobial peptide with mammalian cells. J. Biol. Chem. 281:383-391.
11. Sadler, K., K. D. Eom, J. L. Yang, Y. Dimitrova, and J. P. Tam. 2002. Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7. Biochemistry. 41:14150-14157.
12. Lau, Y. E., A. Rozek, M. G. Scott, D. L. Goosney, D. J. Davidson, and R. E. Hancock. 2005. Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect. Immun. 73:583-591.
13. Matsuzaki, K., O. Murase, H. Tokuda, S. Funakoshi, N. Fujii, and K. Miyajima. 1994. Orientational and aggregational states of magainin 2 in phospholipid bilayers. Biochemistry. 33:3342-3349.
14. Lundberg, M., and M. Johansson. 2002. Positively charged DNA-binding proteins cause apparent cell membrane translocation. Biochem. Biophys. Res. Commun. 291:367-371.
15. Song, Y. M., Y. Park, S. S. Lim, S. T. Yang, E. R. Woo, I. S. Park, J. S. Lee, J. I. Kim, K. S. Hahm, Y. Kim, and S. Y. Shin. 2005. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. Biochemistry. 44:12094-12106.
16. Sandgren, S., A. Wittrup, F. Cheng, M. Jonsson, E. Eklund, S. Busch, and M. Belting. 2004. The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J. Biol. Chem. 279:17951-17956.
17. Powers, J. P., M. M. Martin, D. L. Goosney, and R. E. Hancock. 2006. The antimicrobial peptide polyphemusin localizes to the cytoplasm of Escherichia coli following treatment. Antimicrob. Agents Chemother. 50:1522-1524.
18. Andree, H. A., C. P. Reutelingsperger, R. Hauptmann, H. C. Hemker, W. T. Hermens, and G. M. Willems. 1990. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J. Biol. Chem. 265:4923-4928.
19. Koenig, J. A., R. Kaur, I. Dodgeon, J. M. Edwardson, and P. P. Humphrey. 1998. Fates of endocytosed somatostatin sst2 receptors and associated agonists. Biochem. J. 336:291-298.
20. Poon, G. M., and J. Gariepy. 2007. Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells. Biochem. Soc. Trans. 35:788-793.
21. Balasubramanian, K., and A. J. Schroit. 2003. Aminophospholipid asymmetry: a matter of life and death. Annu. Rev. Physiol. 65:701-734.
22. Kobayashi, S., A. Chikushi, S. Tougu, Y. Imura, M. Nishida, Y. Yano, and K. Matsuzaki. 2004. Membrane translocation mechanism of the antimicrobial peptide buforin 2. Biochemistry. 43:15610-15616.
23. Matsuzaki, K., S. Yoneyama, O. Murase, and K. Miyajima. 1996. Transbilayer transport of ions and lipids coupled with mastoparan X translocation. Biochemistry. 35:8450-8456.
24. Imura, Y., M. Nishida, Y. Ogawa, Y. Takakura, and K. Matsuzaki. 2007. Action mechanism of tachyplesin I and effects of PEGylation. Biochim. Biophys. Acta. 1768:1160-1169.
25. Yang, L., T. A. Harroun, T. M. Weiss, L. Ding, and H. W. Huang. 2001. Barrel-stave model or toroidal model? A case study on melittin pores. Biophys. J. 81:1475-1485.
26. Hallock, K. J., D. K. Lee, and A. Ramamoorthy. 2003. MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain. Biophys. J. 84:3052-3060.
27. Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta. 1462:55-70.
28. Matsuzaki, K., K. Sugishita, N. Ishibe, M. Ueha, S. Nakata, K. Miyajima, and R. M. Epand. 1998. Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry. 37:11856-11863.
29. de Kroon, A. I., J. W. Timmermans, J. A. Killian, and B. de Kruijff. 1990. The pH dependence of headgroup and acyl chain structure and dynamics of phosphatidylserine, studied by 2H-NMR. Chem. Phys. Lipids. 54:33-42.
30. Mangoni, M. L., N. Papo, D. Barra, M. Simmaco, A. Bozzi, A. Di Giulio, and A. C. Rinaldi. 2004. Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coli. Biochem. J. 380:859-865.
31. Hasper, H. E., N. E. Kramer, J. L. Smith, J. D. Hillman, C. Zachariah, O. P. Kuipers, B. de Kruijff, and E. Breukink. 2006. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science. 313:1636-1637.
32. den Kamp, J. O., W. van Iterson, and L. L. van Deenen. 1967. Studies of the phospholipids and morphology of protoplasts of Bacillus megaterium. Biochim. Biophys. Acta. 135:862-884.
33. Tachi, T., R. F. Epand, R. M. Epand, and K. Matsuzaki. 2002. Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity. Biochemistry. 41:10723-10731.
34. Ludtke, S. J., K. He, W. T. Heller, T. A. Harroun, L. Yang, and H. W. Huang. 1996. Membrane pores induced by magainin. Biochemistry. 35:13723-13728.
35. Hrafnsdottir, S., J. W. Nichols, and A. K. Menon. 1997. Transbilayer movement of fluorescent phospholipids in Bacillus megaterium membrane vesicles. Biochemistry. 36:4969-4978.
36. Sato, H., and J. B. Feix. 2006. Osmoprotection of bacterial cells from toxicity caused by antimicrobial hybrid peptide CM15. Biochemistry. 45:9997-10007.
37. Armstrong, J. K., R. B. Wenby, H. J. Meiselman, and T. C. Fisher. 2004. The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation. Biophys. J. 87:4259-4270.
38. Maher, S., and S. McClean. 2006. Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro. Biochem. Pharmacol. 71:1289-1298.
39. Lehmann, J., M. Retz, S. S. Sidhu, H. Suttmann, M. Sell, F. Paulsen, J. Harder, G. Unteregger, and M. Stockle. 2006. Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines. Eur. Urol. 50:141-147.
40. den Hertog, A. L., J. van Marle, H. A. van Veen, W. Van't Hof, J. G. Bolscher, E. C. Veerman, and A. V. Nieuw Amerongen. 2005. Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem. J. 388:689-695.
41. Subbalakshmi, C., V. Krishnakumar, R. Nagaraj, and N. Sitaram. 1996. Requirements for antibacterial and hemolytic activities in the bovine neutrophil derived 13-residue peptide indolicidin. FEBS Lett. 395:48-52.
42. Rinaldi, A. C., M. L. Mangoni, A. Rufo, C. Luzi, D. Barra, H. Zhao, P. K. Kinnunen, A. Bozzi, A. Di Giulio, and M. Simmaco. 2002. Temporin L: antimicrobial, haemolytic and cytotoxic activities, and effects on membrane permeabilization in lipid vesicles. Biochem. J. 368:91-100.
43. Matsuzaki, K., K. Sugishita, N. Fuji, and K. Miyajima. 1995. Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. Biochemistry. 34:3423-3429.
44. Matsuzaki, K., K. Sugishita, M. Harada, N. Fujii, and K. Miyajima. 1997. Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim. Biophys. Acta. 1327:119-130.
45. Virtanen, J. A., K. H. Cheng, and P. Somerharju. 1998. Phospholipid composition of the mammalian red cell membrane can be rationalized by a superlattice model. Proc. Natl. Acad. Sci. USA. 95:4964-4969.
46. Nagan, N., A. K. Hajra, L. K. Larkins, P. Lazarow, P. E. Purdue, W. B. Rizzo, and R. A. Zoeller. 1998. Isolation of a Chinese hamster fibroblast variant defective in dihydroxyacetonephosphate acyltransferase activity and plasmalogen biosynthesis: use of a novel two-step selection protocol. Biochem. J. 332:273-279.
47. Henriques, S. T., M. N. Melo, and M. A. Castanho. 2006. Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem. J. 399:1-7.
48. Klocek, G., and J. Seelig. 2008. Melittin interaction with sulfated cell surface sugars. Biochemistry. 47:2841-2849.
49. Baranska-Rybak, W., A. Sonesson, R. Nowicki, and A. Schmidtchen. 2006. Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids. J. Antimicrob. Chemother. 57:260-265.
50. Bevers, E. M., P. Comfurius, D. W. Dekkers, and R. F. Zwaal. 1999. Lipid translocation across the plasma membrane of mammalian cells. Biochim. Biophys. Acta. 1439:317-330.
51. Wurth, G. A., and A. Zweifach. 2002. Evidence that cytosolic calcium increases are not sufficient to stimulate phospholipid scrambling in human T-lymphocytes. Biochem. J. 362:701-708.
52. Martin, S. J., C. P. Reutelingsperger, A. J. McGahon, J. A. Rader, R. C. van Schie, D. M. LaFace, and D. R. Green. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182:1545-1556.
53. Haukland, H. H., H. Ulvatne, K. Sandvik, and L. H. Vorland. 2001. The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm. FEBS Lett. 508:389-393.
54. Haidekker, M. A., H. Y. Stevens, and J. A. Frangos. 2004. Cell membrane fluidity changes and membrane undulations observed using a laser scattering technique. Ann. Biomed. Eng. 32:531-536.
55. Veerman, E. C., M. Valentijn-Benz, K. Nazmi, A. L. Ruissen, E. Walgreen-Weterings, J. van Marle, A. B. Doust, W. van't Hof, J. G. Bolscher, and A. V. Amerongen. 2007. Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane. J. Biol. Chem. 282:18831-18841.